Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Changing our microbiome: probiotics in dermatology.

Yu Y, Dunaway S, Champer J, Kim J, Alikhan A.

Br J Dermatol. 2019 May 3. doi: 10.1111/bjd.18088. [Epub ahead of print]

PMID:
31049923
2.

CRISPR Gene Drive Efficiency and Resistance Rate Is Highly Heritable with No Common Genetic Loci of Large Effect.

Champer J, Wen Z, Luthra A, Reeves R, Chung J, Liu C, Lee YL, Liu J, Yang E, Messer PW, Clark AG.

Genetics. 2019 May;212(1):333-341. doi: 10.1534/genetics.119.302037. Epub 2019 Mar 27.

PMID:
30918006
3.

Maximum Likelihood Estimation of Fitness Components in Experimental Evolution.

Liu J, Champer J, Langmüller AM, Liu C, Chung J, Reeves R, Luthra A, Lee YL, Vaughn AH, Clark AG, Messer PW.

Genetics. 2019 Mar;211(3):1005-1017. doi: 10.1534/genetics.118.301893. Epub 2019 Jan 24.

PMID:
30679262
4.

Molecular safeguarding of CRISPR gene drive experiments.

Champer J, Chung J, Lee YL, Liu C, Yang E, Wen Z, Clark AG, Messer PW.

Elife. 2019 Jan 22;8. pii: e41439. doi: 10.7554/eLife.41439.

5.

Reducing resistance allele formation in CRISPR gene drive.

Champer J, Liu J, Oh SY, Reeves R, Luthra A, Oakes N, Clark AG, Messer PW.

Proc Natl Acad Sci U S A. 2018 May 22;115(21):5522-5527. doi: 10.1073/pnas.1720354115. Epub 2018 May 7.

6.

Novel CRISPR/Cas9 gene drive constructs reveal insights into mechanisms of resistance allele formation and drive efficiency in genetically diverse populations.

Champer J, Reeves R, Oh SY, Liu C, Liu J, Clark AG, Messer PW.

PLoS Genet. 2017 Jul 20;13(7):e1006796. doi: 10.1371/journal.pgen.1006796. eCollection 2017 Jul.

7.

The role of the vaginal microbiome in gynaecological cancer.

Champer M, Wong AM, Champer J, Brito IL, Messer PW, Hou JY, Wright JD.

BJOG. 2018 Feb;125(3):309-315. doi: 10.1111/1471-0528.14631. Epub 2017 Apr 12. Review.

8.

Analysis of the Surface, Secreted, and Intracellular Proteome of Propionibacterium acnes.

Yu Y, Champer J, Kim J.

EuPA Open Proteom. 2015 Dec;9:1-7. doi: 10.1016/j.euprot.2015.06.003. Epub 2015 Jun 16.

9.

Different Propionibacterium acnes Phylotypes Induce Distinct Immune Responses and Express Unique Surface and Secreted Proteomes.

Yu Y, Champer J, Agak GW, Kao S, Modlin RL, Kim J.

J Invest Dermatol. 2016 Nov;136(11):2221-2228. doi: 10.1016/j.jid.2016.06.615. Epub 2016 Jul 1.

10.

Proteomic Analysis of Pathogenic Fungi Reveals Highly Expressed Conserved Cell Wall Proteins.

Champer J, Ito JI, Clemons KV, Stevens DA, Kalkum M.

J Fungi (Basel). 2016 Mar;2(1). pii: 6. Epub 2016 Jan 12.

11.

Cheating evolution: engineering gene drives to manipulate the fate of wild populations.

Champer J, Buchman A, Akbari OS.

Nat Rev Genet. 2016 Mar;17(3):146-59. doi: 10.1038/nrg.2015.34. Epub 2016 Feb 15. Review.

PMID:
26875679
12.

The role of the cutaneous microbiome in skin cancer: lessons learned from the gut.

Yu Y, Champer J, Beynet D, Kim J, Friedman AJ.

J Drugs Dermatol. 2015 May;14(5):461-5. Review.

PMID:
25942663
13.

Pentobra: A Potent Antibiotic with Multiple Layers of Selective Antimicrobial Mechanisms against Propionibacterium Acnes.

Schmidt NW, Agak GW, Deshayes S, Yu Y, Blacker A, Champer J, Xian W, Kasko AM, Kim J, Wong GCL.

J Invest Dermatol. 2015 Jun;135(6):1581-1589. doi: 10.1038/jid.2015.40. Epub 2015 Feb 10.

14.

Typing of Propionibacterium acnes: a review of methods and comparative analysis.

Yu Y, Champer J, Garbán H, Kim J.

Br J Dermatol. 2015;172(5):1204-9. doi: 10.1111/bjd.13667. Epub 2015 Apr 9. Review.

PMID:
25600912
15.

Resveratrol Demonstrates Antimicrobial Effects Against Propionibacterium acnes In Vitro.

Taylor EJ, Yu Y, Champer J, Kim J.

Dermatol Ther (Heidelb). 2014 Dec;4(2):249-57. doi: 10.1007/s13555-014-0063-0. Epub 2014 Sep 17.

16.

Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB.

Chow A, Zhou W, Liu L, Fong MY, Champer J, Van Haute D, Chin AR, Ren X, Gugiu BG, Meng Z, Huang W, Ngo V, Kortylewski M, Wang SE.

Sci Rep. 2014 Jul 18;4:5750. doi: 10.1038/srep05750.

17.

Chitosan against cutaneous pathogens.

Champer J, Patel J, Fernando N, Salehi E, Wong V, Kim J.

AMB Express. 2013 Jul 6;3(1):37. doi: 10.1186/2191-0855-3-37.

18.

Immunotherapy in invasive fungal infection--focus on invasive aspergillosis.

Lehrnbecher T, Kalkum M, Champer J, Tramsen L, Schmidt S, Klingebiel T.

Curr Pharm Des. 2013;19(20):3689-712. Review.

PMID:
23278541
19.

Protein targets for broad-spectrum mycosis vaccines: quantitative proteomic analysis of Aspergillus and Coccidioides and comparisons with other fungal pathogens.

Champer J, Diaz-Arevalo D, Champer M, Hong TB, Wong M, Shannahoff M, Ito JI, Clemons KV, Stevens DA, Kalkum M.

Ann N Y Acad Sci. 2012 Dec;1273:44-51. doi: 10.1111/j.1749-6632.2012.06761.x.

PMID:
23230836
20.

Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens.

Friedman AJ, Phan J, Schairer DO, Champer J, Qin M, Pirouz A, Blecher-Paz K, Oren A, Liu PT, Modlin RL, Kim J.

J Invest Dermatol. 2013 May;133(5):1231-9. doi: 10.1038/jid.2012.399. Epub 2012 Nov 29.

21.

Nuclear translocation of type I transforming growth factor β receptor confers a novel function in RNA processing.

Chandra M, Zang S, Li H, Zimmerman LJ, Champer J, Tsuyada A, Chow A, Zhou W, Yu Y, Gao H, Ren X, Lin RJ, Wang SE.

Mol Cell Biol. 2012 Jun;32(12):2183-95. doi: 10.1128/MCB.00320-12. Epub 2012 Apr 2.

22.

Make-up adds realism to disaster exercise.

ROBINSON EP, CHAMPER J.

Hospitals. 1962 Mar 16;36:46-9. No abstract available.

PMID:
14492900
23.

Historical and legal aspects of blood transfusions.

CHAMPER J.

Hosp Manage. 1958 Feb;85(2):50 passim. No abstract available.

PMID:
13490947

Supplemental Content

Loading ...
Support Center